Management of stage T1 superficial bladder cancer with intravesical bacillus Calmette-Guerin therapy.
about
Involvement of the Androgen and Glucocorticoid Receptors in Bladder CancerSulforaphane for the chemoprevention of bladder cancer: molecular mechanism targeted approach.Advances in intravesical therapy for the treatment of non-muscle invasive bladder cancer (Review).Best practice in the treatment of nonmuscle invasive bladder cancer.Failure to achieve a complete response to induction BCG therapy is associated with increased risk of disease worsening and death in patients with high risk non-muscle invasive bladder cancer.BCG vaccine in superficial bladder cancer.
P2860
Management of stage T1 superficial bladder cancer with intravesical bacillus Calmette-Guerin therapy.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Management of stage T1 superfi ...... illus Calmette-Guerin therapy.
@ast
Management of stage T1 superfi ...... illus Calmette-Guerin therapy.
@en
type
label
Management of stage T1 superfi ...... illus Calmette-Guerin therapy.
@ast
Management of stage T1 superfi ...... illus Calmette-Guerin therapy.
@en
prefLabel
Management of stage T1 superfi ...... illus Calmette-Guerin therapy.
@ast
Management of stage T1 superfi ...... illus Calmette-Guerin therapy.
@en
P1476
Management of stage T1 superfi ...... cillus Calmette-Guerin therapy
@en
P2093
M F Sarosdy
M S Cookson
P304
P356
10.1016/S0022-5347(17)36724-1
P407
P577
1992-09-01T00:00:00Z